AU2003278814A8 - Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof - Google Patents
Ligands for the peroxisome proliferator-activated receptor, and methods of use thereofInfo
- Publication number
- AU2003278814A8 AU2003278814A8 AU2003278814A AU2003278814A AU2003278814A8 AU 2003278814 A8 AU2003278814 A8 AU 2003278814A8 AU 2003278814 A AU2003278814 A AU 2003278814A AU 2003278814 A AU2003278814 A AU 2003278814A AU 2003278814 A8 AU2003278814 A8 AU 2003278814A8
- Authority
- AU
- Australia
- Prior art keywords
- ligands
- methods
- activated receptor
- peroxisome proliferator
- proliferator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41067702P | 2002-09-13 | 2002-09-13 | |
| US60/410,677 | 2002-09-13 | ||
| PCT/US2003/028931 WO2004024939A2 (en) | 2002-09-13 | 2003-09-12 | Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003278814A8 true AU2003278814A8 (en) | 2004-04-30 |
| AU2003278814A1 AU2003278814A1 (en) | 2004-04-30 |
Family
ID=31994180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003278814A Abandoned AU2003278814A1 (en) | 2002-09-13 | 2003-09-12 | Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003278814A1 (en) |
| WO (1) | WO2004024939A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004113331A1 (en) * | 2003-06-20 | 2004-12-29 | Galderma Research & Development, S.N.C. | Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| GB0403864D0 (en) | 2004-02-20 | 2004-03-24 | Ucl Ventures | Modulator |
| US7820705B2 (en) * | 2004-05-14 | 2010-10-26 | Irm Llc | Compounds and compositions as PPAR modulators |
| PT1852433E (en) | 2004-10-29 | 2012-02-08 | Zeria Pharm Co Ltd | Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| FR2878247B1 (en) | 2004-11-19 | 2008-10-03 | Galderma Res & Dev | NOVEL MODULATING COMPOUNDS OF PPARY RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS |
| WO2006053791A2 (en) * | 2004-11-19 | 2006-05-26 | Galderma Research & Development | Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| AR060901A1 (en) * | 2006-05-12 | 2008-07-23 | Jerini Ag | HETEROCICLICAL COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE OF THESE |
| WO2008044729A1 (en) | 2006-10-12 | 2008-04-17 | Institute Of Medicinal Molecular Design. Inc. | Carboxylic acid derivative |
| US8633245B2 (en) | 2008-04-11 | 2014-01-21 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
| CA2720096A1 (en) * | 2008-04-11 | 2009-10-15 | Institute Of Medicinal Molecular Design, Inc. | Pai-1 inhibitor |
| RU2503443C2 (en) | 2008-11-19 | 2014-01-10 | Пола Кемикал Индастриз Инк. | Anti-wrinkle agents |
| WO2010091142A1 (en) * | 2009-02-04 | 2010-08-12 | President And Fellows Of Harvard College | Compositions and methods for labeling and imaging phospholipids |
| WO2022249113A1 (en) * | 2021-05-25 | 2022-12-01 | 주식회사 자이메디 | Novel compound inhibiting binding between aimp2-dx2 and kras, and use thereof |
-
2003
- 2003-09-12 WO PCT/US2003/028931 patent/WO2004024939A2/en not_active Ceased
- 2003-09-12 AU AU2003278814A patent/AU2003278814A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004024939A2 (en) | 2004-03-25 |
| AU2003278814A1 (en) | 2004-04-30 |
| WO2004024939A3 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL160964A0 (en) | Peroxisome proliferator activated receptor ligand and process for producing the same | |
| AP2223A (en) | Pramipexole once-daily dosage form. | |
| PL375764A1 (en) | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof | |
| AU2002335231A1 (en) | Activator for peroxisome proliferator-activated receptor delta | |
| AU2003233010A8 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
| IL165280A0 (en) | 4-Substituted imidazole-2-thiones and imidazol-2-ones as agpmosts of the alpha-2b and alpha-2c adrenergic receptors | |
| AU2003299791A1 (en) | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity | |
| GB0109414D0 (en) | Well treatment fluids and methods for the use thereof | |
| MXPA03006524A (en) | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands. | |
| IL162669A0 (en) | Antichlinergic agents, method for producing the same and use thereof as medicaments | |
| EP1482985A4 (en) | Technetium-dipyridine complexes, and methods of use thereof | |
| DK1463759T3 (en) | Ligand for the G-protein-coupled receptor GPR43 and uses thereof | |
| AU2003279442A8 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
| IL161578A0 (en) | Peroxisome proliferator activated receptor agonists | |
| AU2003278814A8 (en) | Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof | |
| AU2003290059A8 (en) | Use of cd137 antagonists for the treatment of tumors | |
| IL166821A0 (en) | Novel 1,4-diazabicycloalkane derivatives their preparation and use | |
| GB0427568D0 (en) | Particle-size reduction apparatus, and the use thereof | |
| SG106109A1 (en) | Tomography or curved surfaces | |
| ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
| SI1532141T1 (en) | 2-PYRROLIDIN-2-YL- ?á1,3,4?å-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS | |
| PT2845594T (en) | Use of dihydroimidazolones for the treatment of dogs | |
| TWI348382B (en) | N-acetylglucosamine derivatives, and the use thereof | |
| AU2003296545A8 (en) | Use of a trpm8-activating substance for the treatment of tumours | |
| AU2003277665A1 (en) | Peroxisome proliferator-activated recetor ligand |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |